Abbot NC, Stead LF, White AR, et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2000;(2):CD001008.

American Cancer Society. Cancer Facts & Figures 2012. Atlanta, Ga. 2012.

American Lung Association. Trends in Tobacco Use. 2011. Accessed at www.lungusa.org/finding-cures/our-research/trend-reports/Tobacco-Trend-Report.pdf November 1, 2011.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision (DSM-IV-TR). 2000, Washington DC: American Psychiatric Association.

Bacher I, Houle S, Xu X, et al. Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Arch Gen Psychiatry. 2011;68(8):817−826.

Barnes J, Dong CY, McRobbie H, et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2010;(10):CD001008.

Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci. 2010;116(2):364−374.

Buist AS, McBurnie MA, Vollmer WM , et al, on behalf of the BOLD Collaborative Research Group. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370:741−750.

CDC National Center For Chronic Disease Prevention and Health Promotion. Quit to Live: How and Why to Quit Smoking Today. Accessed at www.cdc.gov/tobacco/news/QuitSmoking.htm on September 12, 2006. Content no longer available.

Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States, 2000–2004. Morb Mort Wkly Rep. 2008;57:1226−1228. Accessed at www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a3.htm on October 26, 2011.

Centers for Disease Control and Prevention (CDC): Smoking Cessation and Interventions Fact Sheet. Accessed at www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm on October 31, 2011.

Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged ≥18 years–United States, 2005-2010. Morb Mortal Wkly Rep. 2011;60(35):1207−1212. Accessed at www.cdc.gov/mmwr/preview/mmwrhtml/mm6035a5.htm?s_cid=mm6035a5_w on October 26, 2011.

Centers for Disease Control and Prevention (CDC). Cigarette Smoking Among Adults and Trends in Smoking Cessation—United States, 2008. Morb Mort Wkly Rep. 2009;58(44):1227−1232. Accessed at www.cdc.gov/mmwr/preview/mmwrhtml/mm5844a2.htm on October 26, 2011.

Clarke LA, Cassidy CW, Catalano G, Catalano MC, Carroll KM. Psychosis induced by smoking cessation clinic administered anticholinergic overload. Ann Clin Psychiatry. 2004;16(3):171−175.

Coleman T, Chamberlain C, Cooper S, Leonardi-Bee J. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction. 2011;106(1):52−61.

Ebbert JO, Burke MV, Hays JT, Hurt RD. Combination treatment with varenicline and nicotine replacement therapy. Nicotine Tob Res. 2009;1:572−576.

Ebbert JO, Hays JT, Hurt RD. Combination pharmacotherapy for stopping smoking: what advantages does it offer? Drugs. 2010;70(6):643−650.

Fagerstrom KO, Hughes JR. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine Tob Res. 2002;4 Suppl 2:573−579.

Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008. Accessed at www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf on October 31, 2011.

Gaither KH, Brunner Huber LR. Thompson ME, Huet-Hudson YM. Does the Use of Nicotine Replacement Therapy During Pregnancy Affect Pregnancy Outcomes? Matern Child Health J. 2009;13:497−504.

Herraiz T, Chaparro C. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Commun. 2005;326(2):378−386.

Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy for nicotine dependence. CA Cancer J Clin. 2005;55:281−299.

Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9:315−327.

Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;(1):CD000031.

Joad JP. Smoking and pediatric respiratory health. Clin Chest Med. 2000;21:37-46,vii-viii.

Joseph AM, Fu SS. Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease. Prog Cardiovasc Dis. 2003;45:429−441.

Joseph AM, Fu SS. Smoking cessation for patients with cardiovascular disease: What is the best approach? Am J Cardiovasc Drugs. 2003;3:339−349.

Keller PA, Beyer EJ, Baker TB, et al. Tobacco Cessation Quitline Spending in 2005 and 2006: What State-Level Factors Matter? Int. J. Environ. Res. Public Health. 2009;6:259−266.

Oncken C, Gonzales D, Nides M, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med. 2006;166:71−77.

Mahmud, A, Feely, J. Effect of Smoking on Arterial Stiffness and Pulse Pressure Amplication. Hypertension. 2003;441:183.

Manufacturer’s product information. September 2010. Accessed at http://us.gsk.com/products/assets/us_zyban.pdf on November 15, 2011.

Medioni J, Berlin I, Mallet A. Increased risk of relapse after stopping nicotine replacement therapies: A mathematical modeling approach. Addiction. 2005;100:247−254.

Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis. 2010;8:8.

Moore D, Aveyard P, Connock M, et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009;338:b1024.

Nides, M. Oncken C, Gonzales D, et al. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo-and bupropion-controlled trial with 1-year follow-up. Arch Intern Med. 2006;166:1561−1568.

Schroeder SA. What to do with a patient who smokes. Grand Rounds at the University of California, San Francisco. JAMA. 2005;294:482−487.

Shiffman S, Ferguson SG, Gwaltney CJ, et al. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy. Psychopharmacology. 2006;184:637−644.

Shiffman S, Scharf DM, Shadel WG, et al. Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol. 2006;74:276−285.

Shiri R, Häkkinen J, Koskimäki J, et al. Smoking causes erectile dysfunction through vascular disease. Urology. 2006;68:1318−1322.

Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146.

Underner M, Paquereau J, Meurice JC. Cigarette smoking and sleep disturbances. Rev Mal Respir. 2006;23 Suppl 3: 67−77.

US Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. 2006. Accessed at www.surgeongeneral.gov/library/secondhandsmoke/report/ on October 31, 2011.

US Department of Health & Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. 1990. Accessed at http://profiles.nlm.nih.gov/NN/B/B/C/T/ on October 31, 2011.

US Department of Health & Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. 2004. Accessed at www.surgeongeneral.gov/library/smokingconsequences/ on October 31, 2011.

US Department of Health & Human Services. The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General. 1988. Accessed at http://profiles.nlm.nih.gov/NN/B/B/Z/D/on October 31, 2011.

US Department of Health & Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General: 1989 Executive Summary. 1989. Accessed at http://profiles.nlm.nih.gov/NN/B/B/X/S/ on October 31, 2011.

US Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. 2000. Accessed at www.cdc.gov/tobacco/data_statistics/sgr/2000/complete_report/index.htm on October 31, 2011.

US Department of Health and Human Services. The Health Consequences of Involuntary Smoking: A Report of the Surgeon General. 1986. Accessed at http://profiles.nlm.nih.gov/NN/B/C/P/M/_/nnbcpm.pdf on October 31, 2011.

US Department of Health and Human Services. US Food and Drug Administration. Summary of Results: Laboratory Analysis of Electronic Cigarettes Conducted By FDA. Accessed at www.fda.gov/NewsEvents/PublicHealthFocus/ucm173146.htm on October 31, 2011.

US Food and Drug Administration. Electronic Cigarettes. Updated 10/6/11. Accessed at www.fda.gov/newsevents/publichealthfocus/ucm172906.htm entitled on October 28, 2011.

US Food and Drug Administration. FDA Acts Against 5 Electronic Cigarette Distributors. (Press Release September 10, 2010.) Accessed at www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm225224.htm on October 31, 2011.

White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev. 2006;(1):CD000009.